Rasio rega marang bathi Acrivon Therapeutics Inc (ACRV)

Lambang korporat lan logo Acrivon (ACRV)

Acrivon Therapeutics (ACRV) revenues rely on the development of oncology therapies via the AP3 system, where the primary catalyst will be the sale of selective agents for treating bladder and ovarian tumors. A technological leap is driven by precision proteomics and the implementation of CHK1/2 inhibitors. The available price action vector with the -0.80 indicator confirms the resilience of a non-cyclical business dependent on clinical success rather than market conditions.

Acrivon Therapeutics Inc (ACRV): Rasio rega marang bathi saka 28.04.2023 nganti 14.11.2026

Rincian analitis perusahaan Acrivon Therapeutics

- kuotasi lan prakiraan analis:
Bagan rega acrivon.com|ACRV - Bagan rega target
- rincian kapitalisasi pasar:
Nilai pasar Acrivon Therapeutics, Inc.|ACRV - Nilai Perusahaan
- informasi kapitalisasi buku:
Nilai Buku saben Saham Acrivon Therapeutics|ACRV - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku acrivon.com|ACRV - Total Aset Perusahaan
- informasi babagan utang lan solvabilitas:
Utang marang Modal Acrivon Therapeutics|ACRV - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Acrivon Pharma|ACRV - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Acrivon Therapeutics, Inc.|ACRV - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Acrivon Therapeutics|Rasio jangkoan perantara acrivon.com
- data bathi resik lan rasio valuasi:
ACRV - Bathi resik perusahaan|Bathi resik sing dikarepake Acrivon Therapeutics|ACRV - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep Acrivon Therapeutics Inc|ACRV - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Acrivon Therapeutics, Inc.|ACRV - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Acrivon Therapeutics|ACRV - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan acrivon.com|ACRV - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Acrivon Therapeutics
- indikator volume dodolan lan pendapatan:
ACRV - Pendapatan lan volume dodolan|Prakiraan dodolan perusahaan acrivon.com|ACRV - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Acrivon Therapeutics, Inc.
Analisis umum perusahaan:ACRV, acrivon.com
Produk asli Acrivon Therapeutics, Inc.

The P/E ratio determines the market value of a single unit of net profit, allowing an investor to assess the extent of overpayment for an asset relative to its actual yield. By analyzing the market valuation via P/E, one can compare financial expectations with the management efficiency of the Acrivon Therapeutics (ACRV) precision oncology platform and the quality of their clinical trials to identify an unjustified price bubble in a timely manner.

Analisis perusahaan pesaing

Rasio rega marang bathi NVCR|Rasio rega marang bathi Alpha Tau Medical (DRTS)|Rasio rega marang bathi FBIO (Fortress Biotech Inc)|Pangali P/E ALLR (Allarity Therapeutics, Inc.)